PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 145 filers reported holding PROTAGONIST THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $271,934 | -36.0% | 16,303 | +5.9% | 0.00% | 0.0% |
| Q2 2023 | $425,155 | +63.3% | 15,393 | +35.9% | 0.00% | 0.0% |
| Q1 2023 | $260,429 | +110.8% | 11,323 | 0.0% | 0.00% | – |
| Q4 2022 | $123,534 | +34.3% | 11,323 | +3.3% | 0.00% | – |
| Q3 2022 | $92,000 | +5.7% | 10,963 | 0.0% | 0.00% | – |
| Q2 2022 | $87,000 | -66.4% | 10,963 | +0.1% | 0.00% | -100.0% |
| Q1 2022 | $259,000 | -30.9% | 10,953 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $375,000 | +95.3% | 10,953 | +1.2% | 0.00% | – |
| Q3 2021 | $192,000 | -59.1% | 10,828 | +3.6% | 0.00% | -100.0% |
| Q2 2021 | $469,000 | +109.4% | 10,448 | +21.1% | 0.00% | – |
| Q1 2021 | $224,000 | – | 8,630 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $56,331,209 | 18.32% |
| Kynam Capital Management, LP | 1,375,000 | $31,625,000 | 4.08% |
| BVF INC/IL | 3,775,900 | $86,845,700 | 3.18% |
| Cormorant Asset Management, LP | 1,700,000 | $39,100 | 2.58% |
| RTW INVESTMENTS, LP | 4,600,799 | $105,818,377 | 2.20% |
| Ghost Tree Capital, LLC | 225,000 | $5,175,000 | 1.53% |
| 683 Capital Management, LLC | 791,000 | $18,193,000 | 1.36% |
| Ikarian Capital, LLC | 211,400 | $4,862,200 | 1.10% |
| Ikarian Capital, LLC | 211,400 | $4,862,200 | 1.10% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 105,486 | $2,426,178 | 1.00% |